Liver transplantation is an increasingly accepted treatment for certain types of hepatic disease. Chronic or advanced hepatic illness frequently causes encephalopathy, but as yet, there have been no studies conducted which have determined if transplantation results in functional recovery from this neurological disorder. The proposed investigation will: 1) elucidate the characteristics of chronic hepatic encephalopathy; 2) serially monitor the pattern and magnitude of change in measured encephalopathy for two years following hepatic transplantation; 3) elucidate the association between the biochemical characteristics of hepatic illness as well as liver morphology characteristics on encephalopathy and, 4) determine if the biochemical and liver morphology characteristics can predict the rate of functional recovery from encephalopathy after liver transplantation. Eighty liver transplantation patients will be compared to forty patients undergoing surgery for peptic ulcer and to eighty normal community dwelling individuals. The subjects will be examined on four occasions matched as closely as possible to each other. The schedule of evaluation is: a) pre-transplantation; b) three months post-transplantation; c) one year post-transplantation; and d) two years post-transplantation. On each occasion, the subjects will receive a comprehensive medical and laboratory workup, as well as an extensive neuropsychiatric assessment. The long term objectives of this research are to elucidate the characteristics and potential for recovery from hepatic encephalopathy, and to determine the efficacy of hepatic transplantation in restoring the person to a productive and healthy life.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
5R01AM032556-02
Application #
3152558
Study Section
Neurology A Study Section (NEUA)
Project Start
1983-12-01
Project End
1987-05-31
Budget Start
1984-12-01
Budget End
1985-11-30
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Van Thiel, D H; Gavaler, J S (1992) Response to HBV vaccination in patients with severe liver disease. Absence of an HLA effect. Dig Dis Sci 37:1447-51
Sakr, M; Zetti, G; Gavaler, J et al. (1992) Effect of renal ischemia on plasma levels of FK 506 in rats. Transplant Proc 24:425-8
Shah, G; Demetris, A J; Gavaler, J S et al. (1992) Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology 103:323-9
Sakr, M; Zetti, G; McClain, C et al. (1992) The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. Transplantation 53:987-91
Hassanein, T; Razack, A; Gavaler, J S et al. (1992) Heatstroke: its clinical and pathological presentation, with particular attention to the liver. Am J Gastroenterol 87:1382-9
Sakr, M; Hassanein, T; Gavaler, J et al. (1992) Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients. Transplantation 53:786-91
Tarter, R E; Switala, J; Arria, A et al. (1991) Impact of liver disease on daily living in transplantation candidates. J Clin Epidemiol 44:1079-83
Berman, D H; Leventhal, R I; Gavaler, J S et al. (1991) Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 100:1129-34
Van Thiel, D H (1991) Gender differences in the susceptibility and severity of alcohol-induced liver disease. Alcohol Alcohol Suppl 1:9-18
Tarter, R E; Switala, J; Arria, A et al. (1991) Quality of life before and after orthotopic hepatic transplantation. Arch Intern Med 151:1521-6

Showing the most recent 10 out of 59 publications